Actively Recruiting
Randomized Suicide Prevention Trial Using ASSIP and ACT in Suicide Attempters
Led by Ardakan University · Updated on 2025-08-20
60
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a randomized controlled trial that aims to compare the effectiveness of two psychological treatment approaches: the Attempted Suicide Short Intervention Program (ASSIP) and Acceptance and Commitment Therapy (ACT). The study seeks to determine which of these two methods is more effective in reducing suicidal ideation and mental pain in individuals who have recently attempted suicide. In this study, 60 participants with a history of suicide attempts will be randomly assigned to three groups. One group will receive ASSIP in addition to treatment as usual (TAU), the second group will receive ACT alongside TAU, and the third group will be a control group receiving TAU only. The results will be assessed using the Beck Scale for Suicide Ideation (BSSI) and the Orbach \& Mikulincer Mental Pain Scale (OMMP) at three stages: pre-test, post-test, and follow-up. The ultimate goal of this research is to provide valuable insights into the comparative effectiveness of ASSIP and ACT interventions for suicide attempters and to contribute to evidence-based suicide prevention strategies. The findings are expected to inform clinical practice and guide future research in this field.
CONDITIONS
Official Title
Randomized Suicide Prevention Trial Using ASSIP and ACT in Suicide Attempters
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Being 18 years of age or older
- Having the ability to read and write
- Providing informed consent to participate in the study
- Having at least one suicide attempt in the past 4 months
You will not qualify if you...
- Having a severe psychiatric or physical illness that interferes with the treatment process
- Receiving concurrent structured psychological interventions (other than TAU) that may interfere with the study's treatment process
- Lack of informed consent to participate in the study
- Substance abuse based on DSM-5 criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Imam Hossein District Health Center
Eslamshahr, Tehran Province, Iran
Actively Recruiting
Research Team
H
Hadiseh Yaghoobi, MA Student
CONTACT
A
Azadeh Choobforoushzadeh, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here